(Q43107640)

14 November 2017

title

Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition (English)

1 reference

14 November 2017

1 reference

1 reference

Tomoyuki Kawamata

1

1 reference

14 November 2017

Yukitoshi Niiyama

series ordinal

2

1 reference

14 November 2017

Jun Yamamoto

series ordinal

3

1 reference

14 November 2017

Shingo Furuse

series ordinal

4

1 reference

14 November 2017

publication date

7 April 2010

1 reference

14 November 2017

published in

Journal of Anesthesia

1 reference

14 November 2017

volume

24

1 reference

14 November 2017

issue

2

1 reference

14 November 2017

page(s)

328-332

1 reference

Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain

14 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00540-010-0919-0

Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo

21 January 2018

1 reference

12 December 2020

Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain

1 reference

12 December 2020

The cloned capsaicin receptor integrates multiple pain-producing stimuli

1 reference

12 December 2020

Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia

1 reference

12 December 2020

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

1 reference

12 December 2020

Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats

1 reference

12 December 2020

Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

1 reference

12 December 2020

Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain

1 reference

12 December 2020

Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord

1 reference

12 December 2020

Impaired nociception and pain sensation in mice lacking the capsaicin receptor

1 reference

12 December 2020

SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain

1 reference

12 December 2020

Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats

1 reference

12 December 2020

Increased Expression of Vanilloid Receptor 1 on Myelinated Primary Afferent Neurons Contributes to the Antihyperalgesic Effect of Capsaicin Cream in Diabetic Neuropathic Pain in Mice

1 reference

12 December 2020

Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.

1 reference

12 December 2020

Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons

1 reference

12 December 2020

N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neu

1 reference

12 December 2020

10.1007/S00540-010-0919-0

Identifiers

DOI

1 reference

14 November 2017

1 reference